NCT00771394View on ClinicalTrials.gov

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

638

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Benign Prostatic HyperplasiaBenign Prostatic HypertrophyOveractive Bladder
Interventions
DRUG

Tamsulosin hydrochloride

oral

DRUG

Solifenacin succinate

oral

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY